MICROSEMI CORPORATION Schedule Reconciling Selected Non-GAAP Financial Measures to Comparable GAAP Financial Measures (unaudited, in millions, except for per share amounts) | ||||||||||||||||
| ||||||||||||||||
|
|
Quarter Ended |
|
Six Months Ended | ||||||||||||
|
|
Mar 30,
|
|
Dec 29,
|
|
Mar 31,
|
|
Mar 30,
|
|
Mar 31,
| ||||||
GAAP gross profit |
|
$ |
145.4 |
|
$ |
138.3 |
|
$ |
133.5 |
|
$ |
283.7 |
|
$ |
276.1 | |
Manufacturing profit in acquired inventory (1) |
|
12.9 |
|
4.8 |
|
— |
|
17.7 |
|
— | ||||||
Non-GAAP gross profit |
|
$ |
158.3 |
|
$ |
143.1 |
|
$ |
133.5 |
|
$ |
301.4 |
|
$ |
276.1 | |
|
|
|
|
|
|
|
|
|
|
| ||||||
GAAP operating income |
|
$ |
4.1 |
|
$ |
7.2 |
|
$ |
11.8 |
|
$ |
11.2 |
|
$ |
37.3 | |
Adjustments to GAAP gross profit |
|
12.9 |
|
4.8 |
|
— |
|
17.7 |
|
— | ||||||
Restructuring and other special charges (2) |
|
6.2 |
|
8.3 |
|
6.9 |
|
14.5 |
|
8.3 | ||||||
Amortization of intangible assets (3) |
|
24.3 |
|
22.0 |
|
21.1 |
|
46.3 |
|
42.8 | ||||||
Stock based compensation (4) |
|
11.4 |
|
10.1 |
|
10.2 |
|
21.5 |
|
18.3 | ||||||
Acquisition costs (5) |
|
0.4 |
|
1.7 |
|
— |
|
2.2 |
|
— | ||||||
Non-GAAP operating income |
|
$ |
59.3 |
|
$ |
54.1 |
|
$ |
50.0 |
|
$ |
113.4 |
|
$ |
106.7 | |
|
|
|
|
|
|
|
|
|
|
| ||||||
GAAP net income (loss) |
|
$ |
(8.7) |
|
$ |
1.4 |
|
$ |
(2.9) |
|
$ |
(7.3) |
|
$ |
11.3 | |
Adjustments to GAAP gross profit and operating income |
|
55.2 |
|
46.9 |
|
38.2 |
|
102.2 |
|
69.4 | ||||||
Loss from facility closure and asset disposal (2) |
|
— |
|
— |
|
0.2 |
|
— |
|
0.2 | ||||||
Credit facility issuance and refinancing costs (6) |
|
0.9 |
|
0.2 |
|
3.3 |
|
1.1 |
|
3.6 | ||||||
(Gain) in debt and derivative instruments (7) |
|
(0.1) |
|
(0.3) |
|
(0.3) |
|
(0.4) |
|
(0.6) | ||||||
Income tax effect on non-GAAP adjustments (8) |
|
0.4 |
|
(5.3) |
|
0.4 |
|
(5.0) |
|
— | ||||||
Non-GAAP net income |
|
$ |
47.7 |
|
$ |
42.9 |
|
$ |
38.9 |
|
$ |
90.6 |
|
$ |
83.9 | |
|
|
|
|
|
|
|
|
|
|
| ||||||
GAAP diluted earnings (loss) per share |
|
$ |
(0.09) |
|
$ |
0.01 |
|
$ |
(0.03) |
|
$ |
(0.08) |
|
$ |
0.12 | |
Effect of non-GAAP adjustments on diluted earnings per share |
|
$ |
0.60 |
|
$ |
0.45 |
|
$ |
0.46 |
|
$ |
1.05 |
|
$ |
0.81 | |
Non-GAAP diluted earnings per share |
|
$ |
0.51 |
|
$ |
0.46 |
|
$ |
0.43 |
|
$ |
0.97 |
|
$ |
0.93 | |
|
|
|
|
|
|
|
|
|
|
| ||||||
Weighted average diluted shares used in calculating non-GAAP diluted earnings per share |
|
94.1 |
|
93.5 |
|
91.1 |
|
93.8 |
|
90.5 | ||||||
|
|
|
|
|
|
|
|
|
|
| ||||||
Operating cash flow |
|
$ |
30.2 |
|
$ |
62.5 |
|
$ |
31.9 |
|
$ |
92.7 |
|
$ |
60.0 | |
Capital expenditures |
|
(8.7) |
|
(12.1) |
|
(9.0) |
|
(20.8) |
|
(17.5) | ||||||
Free cash flow |
|
$ |
21.5 |
|
$ |
50.4 |
|
$ |
22.9 |
|
$ |
71.9 |
|
$ |
42.5 |
|
Additional details reconciling the selected non-GAAP financial measure to the selected GAAP financial measure may be found in "Notes on Non-GAAP Financial Measures." |